Cargando…
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
BACKGROUND: Gene expression signatures indicative of tumor proliferative capacity and tumor-immune cell interactions have emerged as principal biology-driven predictors of breast cancer outcomes. How these signatures relate to one another in biological and prognostic contexts remains to be clarified...
Autores principales: | Nagalla, Srikanth, Chou, Jeff W, Willingham, Mark C, Ruiz, Jimmy, Vaughn, James P, Dubey, Purnima, Lash, Timothy L, Hamilton-Dutoit, Stephen J, Bergh, Jonas, Sotiriou, Christos, Black, Michael A, Miller, Lance D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3798758/ https://www.ncbi.nlm.nih.gov/pubmed/23618380 http://dx.doi.org/10.1186/gb-2013-14-4-r34 |
Ejemplares similares
-
Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
por: Alistar, Angela, et al.
Publicado: (2014) -
The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
por: Stathopoulos, George P., et al.
Publicado: (2014) -
Recent advances in understanding and management of acquired thrombocytopenia
por: Nagalla, Srikanth, et al.
Publicado: (2018) -
Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank
por: Erichsen, Rune, et al.
Publicado: (2010) -
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
por: Wirapati, Pratyaksha, et al.
Publicado: (2008)